Zero Point Five Therapeutics, Inc.
New Form D on file · 2025-04-17 · the record
Before you sell to, join or invest in Zero Point Five Therapeutics, Inc.
MentionFox check on Zero Point Five Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/zero-point-five-therapeutics-inc-form-d-25000001
Check Zero Point Five Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Zero Point Five Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Zero Point Five Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-17.
Zero Point Five Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 17, 2025. The filing reports $4.30M sold. Its industry group is Biotechnology. It names Joseph Amprey III (Executive Officer, Director), Ben Auspitz (Director), Jodi Jahic (Director) (SEC Form D, April 17, 2025).
Is this your company?
Sell to companies like Zero Point Five Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Zero Point Five Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Zero Point Five Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in Maryland, filed within 90 days of this one, largest first.
Get an email when Zero Point Five Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Zero Point Five Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Zero Point Five Therapeutics, Inc. →Get the full cited report on Zero Point Five Therapeutics, Inc.
What the filing shows about Zero Point Five Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Zero Point Five Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Zero Point Five Therapeutics, Inc.'s address as 915 S. Eaton Street, Baltimore, MD 21224.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Zero Point Five Therapeutics, Inc. See pricing
Zero Point Five Therapeutics, Inc. is a registered filer with the SEC (CIK 1985295) and has filed since 2023-07-12. 2 filings are on record, the latest on 2025-04-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Zero Point Five Therapeutics, Inc.'s Form D of 2025-04-17 names Joseph Amprey III, Ben Auspitz and Jodi Jahic as its officers, directors or promoters.
Its new offerings report $11.52M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Joseph Amprey III is named as Executive Officer and Director on the Form D that Zero Point Five Therapeutics, Inc. filed with the SEC on 17 April 2025, one of 3 people that filing names.
Ben Auspitz is named as Director on the Form D that Zero Point Five Therapeutics, Inc. filed with the SEC on 17 April 2025, one of 3 people that filing names.
Jodi Jahic is named as Director on the Form D that Zero Point Five Therapeutics, Inc. filed with the SEC on 17 April 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-04-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Zero Point Five Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Zero Point Five Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Zero Point Five Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Zero Point Five Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Zero Point Five Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Zero Point Five Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Baltimore
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/zero-point-five-therapeutics-inc-form-d-25000001